CANC vs. IDNA ETF Comparison
Comparison of Tema Oncology ETF (CANC) to iShares Genomics Immunology and Healthcare ETF (IDNA)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$26.62
Average Daily Volume
2,712
Number of Holdings
*
43
* may have additional holdings in another (foreign) market
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.Grade (RS Rating)
Last Trade
$23.33
Average Daily Volume
29,488
Number of Holdings
*
34
* may have additional holdings in another (foreign) market
Performance
| Period | CANC | IDNA |
|---|---|---|
| 30 Days | -6.65% | -4.54% |
| 60 Days | -10.02% | -6.96% |
| 90 Days | -10.36% | -6.02% |
| 12 Months | 15.15% | 17.65% |
15 Overlapping Holdings
| Symbol | Grade | Weight in CANC | Weight in IDNA | Overlap | |
|---|---|---|---|---|---|
| ACLX | C | 1.5% | 4.42% | 1.5% | |
| BGNE | D | 2.3% | 5.04% | 2.3% | |
| BPMC | C | 4.05% | 1.46% | 1.46% | |
| CRSP | D | 2.3% | 1.01% | 1.01% | |
| EXEL | B | 2.93% | 6.44% | 2.93% | |
| GILD | B | 5.49% | 5.73% | 5.49% | |
| INCY | C | 4.1% | 5.36% | 4.1% | |
| MRK | F | 2.81% | 2.97% | 2.81% | |
| MRNA | F | 0.72% | 1.13% | 0.72% | |
| NRIX | C | 1.15% | 1.69% | 1.15% | |
| NTLA | F | 1.58% | 0.39% | 0.39% | |
| RCUS | F | 0.67% | 0.88% | 0.67% | |
| REGN | F | 5.25% | 3.22% | 3.22% | |
| RVMD | B | 4.6% | 5.78% | 4.6% | |
| SWTX | C | 2.14% | 2.39% | 2.14% |
CANC Overweight 28 Positions Relative to IDNA
| Symbol | Grade | Weight | |
|---|---|---|---|
| ARGX | A | 4.19% | |
| ILMN | C | 4.16% | |
| AGIO | C | 2.71% | |
| MREO | F | 2.54% | |
| AMGN | D | 2.37% | |
| GH | B | 2.07% | |
| NVS | D | 2.03% | |
| NUVL | D | 1.99% | |
| DAWN | D | 1.9% | |
| GMAB | F | 1.84% | |
| EXAS | D | 1.45% | |
| CLDX | D | 1.44% | |
| SDGR | C | 1.44% | |
| JANX | C | 1.43% | |
| LEGN | D | 1.41% | |
| MRUS | F | 1.37% | |
| LNTH | C | 1.22% | |
| COGT | D | 0.95% | |
| IDYA | F | 0.9% | |
| BNTX | D | 0.89% | |
| BCYC | F | 0.84% | |
| CGEM | F | 0.83% | |
| ORIC | F | 0.76% | |
| RLAY | F | 0.69% | |
| IMCR | C | 0.69% | |
| TERN | F | 0.6% | |
| CGON | F | 0.56% | |
| ARVN | F | 0.46% |
CANC Underweight 19 Positions Relative to IDNA
CANC: Top Represented Industries & Keywords
IDNA: Top Represented Industries & Keywords
Compare ETFs
